INDO US BIOTECH
Back to Cashflow Statement
|
INDO US BIOTECH Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-0.85 Cr | ₹0.91 Cr | ₹0.14 Cr | ₹-0.08 Cr | ₹-0.07 Cr |
What is the latest Net Cash Inflow / Outflow ratio of INDO US BIOTECH ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-0.85 Cr |
| Mar2024 | ₹0.91 Cr |
| Mar2023 | ₹0.14 Cr |
| Mar2022 | ₹-0.08 Cr |
| Mar2021 | ₹-0.07 Cr |
How is Net Cash Inflow / Outflow of INDO US BIOTECH Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.85 Cr | Negative | |
| Mar2024 | ₹0.91 Cr | 544.68 | |
| Mar2023 | ₹0.14 Cr | Positive | |
| Mar2022 | ₹-0.08 Cr | Negative | |
| Mar2021 | ₹-0.07 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹162.8 Cr | -2.4% | -7.4% | -52.2% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,931.5 Cr | -2% | -12.2% | -29.6% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,203.7 Cr | -2% | 5.4% | 4.7% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,089.6 Cr | 0.8% | 2.3% | -4.9% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹965.4 Cr | 7.9% | 1.7% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹485.1 Cr | -4.2% | -12.3% | -15.7% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -2.4% |
-7.4% |
-52.2% |
| SENSEX | -0.1% |
2.4% |
-3.3% |
You may also like the below Video Courses